生物活性 | |||
---|---|---|---|
描述 | Diethylstilbestrol is a synthetic estrogen receptor agonist structurally related to estradiol. Diethylstilbestrol at 20µM results in 30±13% and 43±4% displacement of [3H]-estradiol from the sex hormone-binding globulin steroid-binding site in the serum and dextran-coated charcoal-treated serum[3]. Prostate cancer PC-3 cells treated with 30µM diethylstilbestrol for 72 hours show smaller nuclei compared with the control group. Diethylstilbestrol at 15 and 30µM induces apoptosis of androgen-insensitive prostate cancer cells[4]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00428948 | Polycystic Kidney Disease, Aut... 展开 >>osomal Dominant 收起 << | Phase 3 | Completed | - | - |
NCT00428948 | - | Completed | - | - | |
NCT01212991 | Prostate Cancer | Phase 3 | Active, not recruiting | December 28, 2018 | - |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.73mL 0.75mL 0.37mL |
18.63mL 3.73mL 1.86mL |
37.26mL 7.45mL 3.73mL |
参考文献 |
---|